Current aspects of high-dose chemotherapy in germ-cell tumors
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference56 articles.
1. Testicular germ-cell cancer;Bosl;New Engl. J. Med.,1997
2. International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers;J. Clin. Oncol.,1997
3. Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma;Harstrick;J. Clin. Oncol.,1991
4. Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide;Loehrer;Ann. Intern. Med.,1988
5. First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: a multivariate and matched-pair analysis;Bokemeyer;J. Clin. Oncol.,1999
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hematopoietic Cell Transplantation;Holland-Frei Cancer Medicine;2017-02-26
2. Salvage therapy for refractory or recurrent pediatric germ cell tumors: The french SFCE experience;Pediatric Blood & Cancer;2013-08-12
3. Adénocarcinome gastro-intestinal à composante choriocarcinomateuse : à propos de 2 cas et revue des 120 cas de la littérature;Gastroentérologie Clinique et Biologique;2007-10
4. Recent Advances in Conventional-Dose Salvage Chemotherapy in Patients with Cisplatin-Resistant or Refractory Testicular Germ Cell Tumors;European Urology;2005-09
5. The role of high-dose chemotherapy in relapsed germ cell tumors;World Journal of Urology;2004-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3